fatiguesleepINTRODUCTION/BACKGROUND. Administration of GSK1070806, an anti–IL-18 monoclonal antibody, in patients with atopic dermatitis (AD) resulted in significant clinical improvements versus placebo after 12 weeks. OBJECTIVES. Assessment of patient-reported outcomes (PROs) for patients with AD ...